0001869472-21-000001.txt : 20210721 0001869472-21-000001.hdr.sgml : 20210721 20210721123644 ACCESSION NUMBER: 0001869472-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210721 EFFECTIVENESS DATE: 20210721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fidelis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001869472 IRS NUMBER: 474986278 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-407114 FILM NUMBER: 211103668 BUSINESS ADDRESS: STREET 1: 675 US HIGHWAY ONE, SUITE B113 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 215-262-2078 MAIL ADDRESS: STREET 1: 675 US HIGHWAY ONE, SUITE B113 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 D 1 primary_doc.xml X0708 D LIVE 0001869472 Fidelis Pharmaceuticals, Inc. 675 US HIGHWAY ONE, SUITE B113 NORTH BRUNSWICK NJ NEW JERSEY 08902 215-262-2078 DELAWARE None None Corporation true Cynthia Davis 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Michael Wells 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Director Promoter Barry Levinson 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Director Promoter Andrew Midler 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Director Steven Leary 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Eric Schreiber 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Dennis Steadman 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Director Susan Witham 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Kenneth Sylvester 675 US HIGHWAY ONE, SUITE B113 North Brunswick NJ NEW JERSEY 08902 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-04-26 false true false 0 5129692 5129692 0 About $129,692 of the offering amount is the balance of dividends declared by the LLC that was converted to the Issuer in 2021. false 8 0 0 0 true false Fidelis Pharmaceuticals, Inc. /s/ Cynthia Davis Cynthia Davis CFO 2021-07-21